You are here: Industry Insights > bankruptcy

News List

Opioid Maker Purdue Pharma Expected to File for Bankruptcy drugs
September 10, 2019
Settlement talks with OxyContin maker Purdue Pharma over its role in the U.S. opioid crisis have reached a stalemate and the company is expected to file for bankruptcy...
Purdue Pharma prepares for bankruptcy ahead of opioid crisis trial europeanpharmaceuticalreview
September 06, 2019
A report has found that the rejection of a settlement offer from Purdue has led to the company arranging to file for bankruptcy.
Achaogen seeks near-term sale through bankruptcy process fiercebiotech
April 17, 2019
Achaogen is looking to sell its assets and close out its affairs through the bankruptcy process. News of the Chapter 11 filing comes 10 months after Achaogen won FDA approval for its antibiotic Zemdri.
Novum, best known for astronomical price hikes, files for bankruptcy fiercepharma
February 24, 2019
Novum Pharma made headlines in 2016 when its price hikes prompted CVS to kick the company’s drugs off its formulary. And now, it’s filed for bankruptcy.
Immune Pharmaceuticals Files for Chapter 11 Protection americanpharmaceuticalreview
February 20, 2019
Immune Pharmaceuticals has filed for chapter 11 bankruptcy in the Federal Bankruptcy Court in New Jersey.Despite making progress towards a bertilimumab strategic transaction....
Bausch Health inks $200M ‘stalking horse’ deal for bankrupt Trulance maker Synergy fiercepharma
December 14, 2018
Could a still-recovering company buying a distressed one create a better business? Bausch Health apparently thinks so when it comes to Synergy Pharma, as it's agreed to pay $200 million for the now-bankrupt maker of Trulance.